Ergonomic protective air filtration devices and methods for manufacturing the same
    52.
    发明授权
    Ergonomic protective air filtration devices and methods for manufacturing the same 有权
    符合人体工程学的防护空气过滤装置及其制造方法

    公开(公告)号:US08905034B2

    公开(公告)日:2014-12-09

    申请号:US13290972

    申请日:2011-11-07

    摘要: Ergonomic protective air filtration devices and methods for manufacturing the same are disclosed herein. An ergonomic protective air filtration device includes a stack of at least two layers of an air permeable material, the stack forming a body, a periphery, and a back; a plurality of intersecting three-dimensional V-shaped pleats extending from the periphery and into the stack of layers, so the back of the device defines a breathing chamber adapted to cover a mouth and a nose of the wearer; and a retaining means engaging the body of the device to secure the device to a face of the wearer and to create the breathing chamber. The ergonomic protective air filtration device provides protection against contaminated droplets, fluid splashes, solid particulates, pathogenic microorganisms, or aerosoled air pollutions.

    摘要翻译: 本文公开了人体工程学保护性空气过滤装置及其制造方法。 符合人体工程学的保护性空气过滤装置包括至少两层透气材料的叠层,所述叠层形成主体,周边和背部; 多个相交的三维V形褶皱,其从周边延伸到层叠体,因此装置的背面限定适于覆盖穿戴者的嘴和鼻子的呼吸室; 以及保持装置接合所述装置的主体以将所述装置固定到所述佩戴者的面部并且产生所述呼吸室。 符合人体工程学的保护性空气过滤装置提供防止污染的液滴,流体飞溅,固体颗粒物,致病微生物或气溶胶空气污染物的保护。

    Method for immunizing an avian species
    53.
    发明授权
    Method for immunizing an avian species 有权
    免疫禽类物种的方法

    公开(公告)号:US08859233B2

    公开(公告)日:2014-10-14

    申请号:US12299247

    申请日:2007-05-01

    摘要: The present invention relates to a method for generating a plurality of different IgY antibodies, by immunizing each of a plurality of avian organisms of the same or different species with a composition comprising a plurality of different antigens, thereby generating a plurality of different IgY antibodies.

    摘要翻译: 本发明涉及通过用包含多种不同抗原的组合物免疫相同或不同种类的多个禽类生物体中的每一种从而产生多种不同的IgY抗体来产生多种不同的IgY抗体的方法。

    Vegetable oil composition containing palm mid-fraction fat and method of reducing plasma cholesterol
    55.
    发明授权
    Vegetable oil composition containing palm mid-fraction fat and method of reducing plasma cholesterol 有权
    含有棕榈中级脂肪的植物油组合物和降低血浆胆固醇的方法

    公开(公告)号:US08809388B2

    公开(公告)日:2014-08-19

    申请号:US13669563

    申请日:2012-11-06

    摘要: A method and composition for reducing the cholesterolemic effect in mammals of ingesting a blended nutritional fat composition containing a palm mid-fraction (PMF) hardstock fat combined with an unsaturated vegetable oil. The composition is solid or semi-solid at 20° C. and fluid at 35° C., and includes between 15% and 45% by weight linoleic acid. The weight ratio of disaturated triglyceride (DST) molecules to trisaturated triglyceride (TST) molecules is greater than 10:1, and the PMF hardstock fat contains approximately 50% to 95% by weight DST molecules, the majority of which contain either palmitic acid or a combination of palmitic and stearic acids at the sn-1 and sn-3 triglyceride positions and either oleic acid or linoleic acid at the sn-2 molecular position.

    摘要翻译: 一种用于降低哺乳动物摄入含有棕榈中心(PMF)硬脂肪脂肪与不饱和植物油组合的营养脂肪组合物的胆固醇血症效应的方法和组合物。 组合物在20℃为固体或半固体,在35℃下为流体,并且包含15重量%至45重量%的亚油酸。 饱和甘油三酯(DST)分子与三饱和甘油三酯(TST)分子的重量比大于10:1,PMF硬骨脂肪含有约50%至95%(重量)的DST分子,其大部分含有棕榈酸或 sn-1和sn-3甘油三酯位置上的棕榈酸和硬脂酸的组合以及在sn-2分子位置的油酸或亚油酸的组合。

    IL-4-derived peptides for modulation of the chronic inflammatory response and treatment of autoimmune diseases
    60.
    发明授权
    IL-4-derived peptides for modulation of the chronic inflammatory response and treatment of autoimmune diseases 有权
    用于调节慢性炎症反应和治疗自身免疫疾病的IL-4衍生肽

    公开(公告)号:US08546321B2

    公开(公告)日:2013-10-01

    申请号:US13127574

    申请日:2009-11-17

    IPC分类号: A61K38/00 A61K38/03

    摘要: The present invention relates to small peptides derived from a cytokine, interleukin-4 (IL-4), capable of binding to the IL-4 receptors and inhibiting macrophage activation, and thereby preventing the onset of inflammatory response. The invention further relates to use of said peptides for the production of a medicament for the treatment of different pathological conditions, wherein IL-4 plays a prominent role.

    摘要翻译: 本发明涉及能够结合IL-4受体并抑制巨噬细胞活化的细胞因子,白细胞介素-4(IL-4)的小肽,从而防止炎性反应的发生。 本发明还涉及所述肽用于生产用于治疗不同病理状况的药物的用途,其中IL-4起突出作用。